Crossref

1. Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis

- Qin Wu

- Cong Wang

- En Qiang Chen

- Hong Tang

- Zhen Zhen Li

- Xue Zhong Lei

2. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals

- Khashayar Hesamizadeh

- Heidar Sharafi

- Mohammad Saeid Rezaee-Zavareh

- Bita Behnava

- Seyed Moayed Alavian

3. Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection

- Heidar Sharafi

- Mehri Nikbin

- Seyed Hoda Alavian

- Bita Behnava

- Seyed Moayed Alavian

4. Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis

- Lotfollah Davoodi

- Babak Masoum

- Mahmood Moosazadeh

- Hamed Jafarpour

- Mohammad Haghshenas

- Tahoora Mousavi

5. Predictors of Pegylated Interferon Alpha and Ribavirin Efficacy and Long-Term Assessment of Relapse in Patients With Chronic Hepatitis C: A One-Center Experience From China

- Qin Wu

- Feng Yu Zhan

- En Qiang Chen

- Cong Wang

- Zhen Zhen Li

- Xue Zhong Lei

6. The Effectiveness of Sofosbuvir and Daclatasvir in the Treatment of Hepatitis C in Thalassaemia Major Patients and their Effect on Haematological Factors

- Farhad Zamani

- Hossein Ajdarkosh

- Fahimeh Safarnezhad-Tameshkel

- Azita Azarkeivan

- Hossein Keyvani

- Farshad Naserifar

- Jamshid Vafaeimanesh

7. WITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens

- Jamshid Vafaeimanesh

- Fahimeh Safarnezhad Tameshkel

- Hossein Ajdarkosh

- Azita Azarkeyvani

- Mahmoodreza Khoonsari

- Amirhossein Faraji

- Masoudreza Sohrabi

- Sima Aten

- Hossein Keyvani

- Farhad Zamani

8. Navigating Evolving Challenges in Blood Safety

- Mahmoud Reza Pourkarim

9. Codon usage of human hepatitis C virus clearance genes in relation to its expression

- Pratichi Singh

- Arthi Venkatesan

- Parasuraman Padmanabhan

- Balazs Gulyas

- Febin Prabhu Dass J

10. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation

- Masahiro Shinoda

- Hirotoshi Ebinuma

- Osamu Itano

- Yoshiyuki Yamagishi

- Hideaki Obara

- Minoru Kitago

- Nobuhiro Nakamoto

- Taizo Hibi

- Hiroshi Yagi

- Yuta Abe

- Kentaro Matsubara

- Po‐sung Chu

- Yuko Wakayama

- Nobuhito Taniki

- Akihiro Yamaguchi

- Ryusuke Amemiya

- Rei Miyake

- Takamasa Mizota

- Takanori Kanai

- Yuko Kitagawa

11. Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study

- Seyyed Mohammad Miri

- Heidar Sharafi

- Shima Salimi

- Farah Bokharaei-Salim

- Bita Behnava

- Maryam Keshvari

- Pegah Karimi Elizee

- Hosein Keyvani

- Seyed Moayed Alavian

12. A facile PCR‐RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms

- Seyed Ehsan Alavian

- Heidar Sharafi

- Paniz Shirmast

- Seyed Moayed Alavian

- Bita Behnava

- Mohammad Pouryasin

- Maryam Keshvari

- Ali Pouryasin

13. Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study

- Fahimeh Safarnezhad Tameshkel

- Mohammad Hadi Karbalaie Niya

- Bahareh Amirkalali

- Nima Motamed

- Jamshid Vafaeimanesh

- Mansooreh Maadi

- Masodreza Sohrabi

- Amir Hossein Faraji

- Mahmoodreza Khoonsari

- Hossein Ajdarkosh

- Mehdi Nikkhah

- Elham Sobh Rakhashankhah

- Farhad Zamani